home > ict > summer 2019 > the long and short of cro selection
International Clinical Trials

The Long and Short of CRO Selection

Over recent years, there has been a progression in companies outsourcing their pharmacovigilance to CROs that either specialise in this area or as part of the suite of services they offer. It is clear that there is much work to be done before deciding on which CRO to choose, and there are several factors that need to be considered by the sponsor or licence holder.

Once the decision is taken to outsource, because each company/sponsor is unique, the demands and requirements of the CRO will differ, and it is important to know it has the expertise for immediate and possible long-term needs.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

About the author

Graeme Ladds has worked in pharmacovigilance and medical services for the last 30 years, specialising in both global clinical development and postmarketing for a variety of large and small pharma companies in senior positions. For the last 16 years, Graeme has worked at his own CRO, PharSafer, engaging with clients worldwide and helping them gain licensure and postmarketing for many countries. He also teaches and trains in pharmacovigilance around the world for many companies and works for clients on many product acquisitions and sales (divestments).

Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Convergence in the Pharmaceutical Market

PCI Pharma Services

Convergence is currently playing a large part in the growth of the pharmaceutical market. The need for convergence is due to many factors including the declining economy and high competition within the sector. There are many convergences within this sector to date; these include the convergence of food based products with medical and health products and the convergence of prescription drugs to over the counter (OTC) products. Although convergence is helping the pharmaceutical industry expand and develop, it also poses some challenges; these include the regulatory outlook and counterfeiting.
More info >>

Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement